S119: PRELIMINARY RESULTS OF A PHASE 1 STUDY IN HEALTHY SUBJECTS ADMINISTERED INCLACUMAB, A FULLY HUMAN IGG4 ANTI-P-SELECTIN MONOCLONAL ANTIBODY IN DEVELOPMENT FOR TREATMENT OF SICKLE CELL DISEASE - C Mayer; D Cooper; A Redfern; X Geng; J Shi; M Zutphen-van Geffen; I Kuan; K Koek; H Kastrissios; K Patel; M Davis; P Yue (HemaSphere, 2022)